Clinical Trials Logo

Clinical Trial Summary

Evaluate the application of the new therapeutic model post Fast Track surgery, in complicated acute appendicitis, in pediatric population on the rate of complications postoperative in the form of abdominal abscesses.


Clinical Trial Description

Complicated appendicitis is defined as the finding in the intraoperative study of a perforated, gangrenous or contaminated appendix with the presence of periappendicular abscess. In November 2005, the synthesis of an "Evidence-based clinical practice guide for acute appendicitis in pediatrics" at the Hospital Vall d'Hebron, the result of a committee of experts in the field. This protocol has been the guideline for our center in recent years. Currently, the therapeutic approach is based on monotherapy antibiotic management (except for drug allergies, appendicular peritonitis, immunosuppression or nosocomial acquisition) in the postoperative period, with a minimum duration of 5 days (intravenous treatment). Therefore, the minimum hospital stay in these patients is expected to be equal to or more than 5 days. Acute appendicitis represents the most frequent cause of acute abdomen in pediatric patients older than two years. It affects approximately 80,000 children in the European Union, making appendectomy one of the most frequent non-elective pediatric interventions performed by pediatric surgeons. In recent years, several ambispective studies have been carried out at national level applying new therapeutic models that allow shortening the hospital stay by applying more lax discharge criteria and reducing the duration of intravenous antibiotic treatment, without significant alterations in the rate of postoperative complications. By reducing hospital stay, the fast-track model not only brings clinical benefits to patients, but also economic benefits to the healthcare system. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05761080
Study type Interventional
Source Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Contact Carlos Leganes, MD
Phone +34935537635
Email cleganes@santpau.cat
Status Recruiting
Phase Phase 4
Start date April 22, 2021
Completion date December 2026

See also
  Status Clinical Trial Phase
Completed NCT02784704 - Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections Phase 3
Recruiting NCT06102239 - New Diagnostic Markers In Dignosis Of Complicated Appendix N/A
Recruiting NCT04803422 - Per Oral Versus Intravenous Postoperative Antibiotics After Surgery for Complicated Appendicitis. N/A
Terminated NCT03795194 - Antibiotic Duration in Post-appendectomy Abscess Phase 4
Completed NCT05375058 - Complicated Appendicitis During the COVID-19 Pandemic in Jordan
Completed NCT03159754 - Optimal Care of Complicated Appendicitis Phase 4
Completed NCT01678365 - Safety and Efficacy of Single Daily Dose of Ceftriaxone and Metronidazole for Treatment of Complicated Appendicitis in Children Phase 4
Completed NCT05470517 - Antibiotic Instillation in Appendicitis Phase 2
Completed NCT03712657 - ERAS for Pediatric Acute Appendicitis N/A
Completed NCT05012839 - Complicated Appendicitis in COVID-19 Era
Completed NCT05005104 - Causes of Complicated Appendicitis at Referral Hospital